FTC Testimony: Stopping Pay-for-Delay Drug Settlement Agreements is a Top Competition Priority
Date
In testimony today before the U.S. House of Representatives Committee on the Judiciary, Subcommittee on Courts and Competition Policy, the Federal Trade Commission details its work to promote...